Zachary M. Working, MD

Orthopaedic Traumatologist
Oregon Health & Science University
Oregon Health & Science University
Portland, Oregon, United States

Presentation(s):

• BSFF/ISFR Symposium I: Early Clinical Determination/Detection of Nonunion

  Wednesday, October 23, 2024
  7:45 AM - 7:55 AM EDT

  Financial Disclosures: European Journal of Orthopaedic Surgery and Traumatology: Editorial or governing board|Journal of Orthopaedic Trauma: Editorial or governing board|Orthopaedic Trauma Association: Board or committee member|

• Biomarker to Endochondral Phase of Fracture Repair Demonstrates Differences Between Early and Delayed Long Bone Healing

  Wednesday, October 23, 2024
  8:43 AM - 8:47 AM EDT

  Financial Disclosures: European Journal of Orthopaedic Surgery and Traumatology: Editorial or governing board|Journal of Orthopaedic Trauma: Editorial or governing board|Orthopaedic Trauma Association: Board or committee member|

• Collagen X Fracture Biomarker Suggests Surgical Intervention for Fracture Nonunion Drives Endochondral Bone Response

  Wednesday, October 23, 2024
  8:47 AM - 8:51 AM EDT

  Financial Disclosure N/A

• BSFF Podium Session III: Infection and PTOA

  Wednesday, October 23, 2024
  12:40 PM EDT

  Financial Disclosures: European Journal of Orthopaedic Surgery and Traumatology: Editorial or governing board|Journal of Orthopaedic Trauma: Editorial or governing board|Orthopaedic Trauma Association: Board or committee member|

• Intravenous Iron Infusion Mitigates Platelet Exhaustion and Improves Secretory Response to Agonists in Orthopaedic Trauma Patients

  Wednesday, October 23, 2024
  4:03 PM - 4:07 PM EDT

  Financial Disclosure N/A

• Intravenous Iron Therapy Alters the Inflammatory Cascade Following Orthopaedic Trauma: A Pilot Randomized Controlled Trial

  Wednesday, October 23, 2024
  4:07 PM - 4:10 PM EDT

  Financial Disclosure N/A

• Intravenous Iron Therapy (IVIT) Improves Patient-Reported Outcomes and Immunothrombotic Response Following Orthopaedic Trauma: A Pilot Randomized Controlled Trial

  Thursday, October 24, 2024
  3:46 PM - 3:52 PM EDT

  Financial Disclosure N/A